)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
MiMedx Group (MDXG) investor relations material
MiMedx Group Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary29 Oct, 2025
Executive summary
Achieved record quarterly net sales of $114 million in Q3 2025, up 35% year-over-year, with wound products up 40% and surgical products up 26%.
Adjusted EBITDA reached $35 million (31% of net sales), the highest in company history, with robust free cash flow and a net cash position of $124 million.
Net income for Q3 2025 was $17 million, more than doubling from Q3 2024, with diluted EPS of $0.11.
Launched new products (EPIXPRESS, HELIOGEN, CELERA, EMERGE) and advanced strategic collaborations, supporting portfolio diversification and market expansion.
Cash and cash equivalents rose to $142 million as of September 30, 2025, up from $104 million at year-end 2024.
Financial highlights
Q3 2025 gross profit was $95 million, with gross margin improving to 84% from 82% year-over-year; adjusted gross margin was 88%.
Operating income for Q3 2025 was $22.2 million, up from $11.2 million in Q3 2024.
Free cash flow for Q3 2025 was $29 million, up from $19 million in Q3 2024; for the nine months ended September 30, 2025, it was $48 million.
For the nine months ended September 30, 2025, net sales were $300.5 million, up 17.4% year-over-year.
Adjusted net income for Q3 2025 was $23 million ($0.15/share).
Outlook and guidance
2025 net sales growth outlook raised to mid-to-high teens percentage range; adjusted EBITDA margin projected to be at least mid-20%.
Expects full-year non-GAAP gross margin around 85%; sales and marketing expenses to be 49–50% of net sales, G&A at 14–15%, and R&D at 3%.
CMS proposed reimbursement changes for skin substitutes may impact the business starting January 1, 2026, with final rules expected by year-end.
MIMEDX's strategy for 2026 CMS rules
Q3 gross margin expansion: product drivers?
Which non-GAAP adjustments recently ceased?
MiMedx's strategy to capitalize on CMS reforms
Surgical business growth drivers and future focus
M&A focus areas given strong cash balance
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next MiMedx Group earnings date
Q4 202527 Feb, 2026
Next MiMedx Group earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
MiMedx Group Inc. is a biopharmaceutical company specializing in regenerative medicine. The company develops and markets advanced products derived from human placental tissue to support wound healing and tissue repair. MiMedx’s solutions are used in areas such as chronic wound care, surgical applications, and musculoskeletal conditions. The company is headquartered in Marietta, Georgia, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage